3D Imaging Drug Design and Development LLC

Overview

3D Imaging Drug Design and Development LLC is a private biopharmaceutical company that utilizes advanced 3D imaging technology to revolutionize drug design and development. The company is dedicated to improving therapeutic outcomes through innovative research and development processes.

Core services & business areas

Drug DesignMolecular Modeling3D ImagingPreclinical DevelopmentIn Silico Screening

Therapeutic areas

API / Drug Master Files

3D Imaging Drug Design and Development LLC holds 13 active (15 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • "89ZR-LINTUZUMAB INJECTIONActive2026-04-28
  • Zr89-YS5Active2024-10-01
  • I-124 HJAA-F11Active2024-09-17
  • ZR89 OXINEActive2021-08-09
  • 89 ZR-DARATUMUMABActive2020-12-31
  • (F-18) CLOFARABINEActive2020-10-06
  • 89ZR-DINUTUXIMABActive2020-07-29
  • ZIRCONIUM-89 OXALATEActive2017-02-22
  • I-124-MIBG INJECTIONActive2014-10-27
  • DPA-713 I 124 INJECTIONActive2013-10-01
  • FLUOROMISONIDAZOLE F 18 INJECTIONActive2013-07-19
  • SODIUM IODIDE I 124Active2012-03-23
  • [I-124] FIAU (FIALURIDINE)Active2010-07-23
  • [I-124]CLR1404 INJECTIONInactive2013-12-27
  • [F-18] FDPNInactive2010-09-15

FDA compliance signals

12 FDA enforcement records linked to this company.

  • warning_letter2025-12-04

    FDA Warning Letter (drug product)

  • 4832024-01-31

    Failure to develop written procedures

  • 4832017-04-20

    Prevention of contamination

  • 4832017-04-20

    Written QA procedures established, followed

  • 4832017-04-20

    Determination need for investigation

  • 4832017-04-20

    Equipment not clean

  • 4832017-04-20

    Testing Procedures- Conformance to Standards

  • 4832017-04-20

    Failure to develop written procedures

  • 4832017-04-20

    Adequate controls (general)

  • 4832017-04-20

    Use of reliable suppliers

  • 4832017-04-20

    Lab written procedures

  • 4832017-04-20

    Master Production and Control Records

Verified Supplier Partner

Is this 3D Imaging Drug Design and Development LLC? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.